Wednesday, July 6, 2022
HomeClimate411“Remdesivir for COVID-19” Study accidentally proved effectiveness of Hydroxychloroquine

“Remdesivir for COVID-19” Study accidentally proved effectiveness of Hydroxychloroquine

-

The use of Remdesivir for COVID-19 was authorized by the FDA based on a single RCT, conducted by NIAID with the participation of Gilead Sciences, the exclusive manufacturer of Remdesivir. A final report from this study was published on October 8, five months after the drug’s authorization.

- Advertisment -

Related Articles

China Rejects NASA Claim They Want to Take Over the Moon

 A fascinating war of words has erupted between NASA and the CCP, over China's space intentions.

Norway Heatwaves Are Perfectly Normal, Despite What Paul Krugman Says

Temperatures in the 80s are perfectly normal in the north of Norway, such as Tromso:

Dumb As It Gets: Germany Heads into Winter Refusing to Let Badly Needed Power Plants Operate

It’s about 5.6 million jobs affected by the lack of natural gas. It is not about taking shorter showers.